Watanabe Todd
Reporting owner on Forms 3, 4 and 5, CIK 1801061.
Watanabe Todd reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ARQT · Arcutis Biotherapeutics, Inc.CIK 1787306 | director, officer (See Remarks) | 2 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ARQT · Arcutis Biotherapeutics, In…Common Stock | 2026-11-13 | G gifted | -144,232 | $0 | 568,594 | Form 4 |
| ARQT · Arcutis Biotherapeutics, In…Common Stock | 2026-11-02 | S sold | -4,377 | $31.8634 | 712,826 | Form 4 |
| ARQT · Arcutis Biotherapeutics, In…Common Stock, holding | 25,410 | Form 4 | ||||
| ARQT · Arcutis Biotherapeutics, In…Common Stock, holding | 25,410 | Form 4 | ||||
| ARQT · Arcutis Biotherapeutics, In…Common Stock, holding | 57,358 | Form 4 | ||||
| ARQT · Arcutis Biotherapeutics, In…Common Stock, holding | 124,956 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-074471 | Arcutis Biotherapeutics, Inc. | 2026-11-17 | ||
| Form 4 0001628280-26-070381 | Arcutis Biotherapeutics, Inc. | 2026-11-04 |